Clinical trialNCT02322762CompletedObservational

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings

SponsorAstraZenecaEnrollment15,992Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bong Soo Cha, Dr.
Severance Hospital, Yonsei University Health System
Principal Investigator
clinicaltrials.gov ↗
Jesus Medina, PhD
AstraZeneca
Study Director
clinicaltrials.gov ↗
Linong Ji, MD
Peking University People's Hospital, China
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

303 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Algeria

Research Site
Algiers, Algeria
Research Site
Batna City, Algeria
Research Site
Blida, Algeria
Research Site
Constantine, Algeria
Research Site
Oran, Algeria
Research Site
Sétif, Algeria

Argentina

Research Site
Buenos Aires, Argentina
Research Site
Chacabuco, Argentina
Research Site
Ciudad Autonoma Buenos Aires, Argentina
Research Site
Corrientes, Argentina
Research Site
Córdoba, Argentina
Research Site
Paraná, Argentina
Research Site
Rosario, Argentina
Research Site
San Miguel de Tucumán, Argentina
Research Site
Santa Fe, Argentina

Australia

Research Site
Blacktown, Australia
Research Site
Burwood, Australia
Research Site
Castle Hill, Australia
Research Site
Coorparoo, Australia
Research Site
Corio, Australia
Research Site
Cowra, Australia
Research Site
Edmonton, Australia
Research Site
Forbes, Australia
Research Site
Garran, Australia
Research Site
Ipswich, Australia
Research Site
Melbourne, Australia
Research Site
Sherwood, Australia
Research Site
Smithfield, Australia
Research Site
South Lake, Australia

Austria

Research Site
Feldbach, Austria
Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Linz, Austria
Research Site
Salzburg, Austria
Research Site
Sankt Veit im Pongau, Austria
Research Site
Stankt Stefan Ob Stainz, Austria
Research Site
Vienna, Austria

Bahrain

Research Site
Bahrain, Bahrain

Brazil

Research Site
Belo Horizonte, Brazil
Research Site
Brasília, Brazil

263 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Dec 2014
Primary completion: 21 Aug 2019
Completion: 21 Aug 2019
Last update posted: 9 Jun 2022
Registered enrollment: 15,992
Registry id: NCT02322762

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.